Apnat - Apalutamide 60mg 120 Tablets (Erleada) - Anticancer Medication

APALUTAMIDE 60 mg (Apnat) x 120 Tablets

$1650.00 $800.00
image Prescription Required

APALUTAMIDE 60 mg, an anti-androgen medication used in the treatment of non-metastatic castration-resistant prostate cancer (nmCRPC) and metastatic castration-sensitive prostate cancer (mCSPC).

Generic Name Apalutamide
Manufacturer Natco Pharma Ltd
Packing 120 Tablets
Prescribed For Prostate Cancer
Availability In Stock
Shipping to USA, UK, Australia, Canada, New Zealand, Philippines, Tunisia, France, Italy, South Korea, Albania, Romania, Hong Kong, Malaysia, Thailand, Singapore, Japan, UAE, Saudi Arabia, Qatar, Kuwait, Georgia, Mexico, and many other countries.

Contact us on WhatsApp

Genuine Medicines

Quick Air Delivery

Secure Payment

24/7 Support

Benefits of APALUTAMIDE 60 mg

  • Helps manage advanced prostate cancer
  • Targets hormone-sensitive cancer cells
  • Supports effective cancer treatment
  • Helps reduce cancer progression
  • Used in androgen deprivation therapy
  • Supports better long-term cancer care

Side Effects

  • Fatigue or tiredness
  • Skin rash
  • Joint pain
  • Hot flashes
  • Decreased appetite
  • Weight loss
  • High blood pressure
  • Diarrhea
  • Nausea
  • Falls or fractures (due to reduced bone density)

Caution

  • Take as prescribed, with or without food.
  • Do not skip or stop doses.
  • Inform your doctor of liver, heart, or kidney issues.
  • Monitor liver function, blood pressure, and blood counts.
  • Avoid grapefruit.
  • Do not share medication.
  • Store in a cool, dry place.

Disclaimer

This website operates in compliance with applicable pharmaceutical laws. All content and data available on this website are intended solely for informational purposes. The information provided is not a substitute for professional medical advice, diagnosis, or treatment. Information provided here is for general awareness and does not replace medical advice. We strongly encourage you to consult a qualified healthcare professional for guidance.

Author

Reviewed By

Dr. Abhinav Narang

Doctor of Medicine (MD) | Professional Interest in Oncology

Dr. Abhinav Narang holds a Doctor of Medicine (MD) degree and has a professional interest in oncology and cancer care. His interests include anticancer therapies, monitoring treatment response, managing treatment-related side effects and providing supportive care throughout the patient’s treatment journey.

Need assistance? Chat with us